Scholars Central

Conference abstractPublished 12 Nov 2013

Myrica rubra fruit drink sub-chronic toxicity and hepatoprotective effect in rats

Authors: Mohamed Fahad AlAjmi, Badraddin Mohammed Al-Hadiya, Kamal Eldin Hussein El Tahir

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: This study dealt with the effect of the subchronic toxicity of Myrica rubra fruit beverage drink (MRD) in rats and its hepatoprotective effect against carbon tetrachloride (CCl4)-induced hepatotoxicity. Methodology: Different groups of normal male and female Wistar rats were treated with 50% MRD as drinking vehicle (13 weeks), as substitution of the normal drinking water. Coulter Counter was used for red blood corpuscles (RBCs) and white blood corpuscles (WBCs) count. The Reflotron instrument and Reflotron haemoglobin kit used for determination of haemoglobin content, while the Reflotron strips for determination of blood glucose, total triglycerides and cholesterol contents, blood enzymatic levels, and bilirubin. Atomic absorption spectroscopy was used for determination of blood Na+, Mg++ and Ca++ concentrations. Principal findings: Treatment induced significant increases in the red blood corpuscles (RBCs) count, haematocrit and haemoglobin content. It also significantly decreased plasma levels of total cholesterol and the low-density lipoproteins (LDL) without affecting the levels of high-density lipoproteins (HDL), glucose, triglycerides and bilirubin, together with the significant decrease in hepatic malonaldehyde production. The treatment resulted in significant reductions in the enzymes alanine transiminase (ALT), aspartate aminotransferase (AST) and Alkaline phosphatase (ALP) and a significant diuretic effect. Conclusion: The results of the study point to the potential of Myrica rubra fruit drink to act as a new functional food.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Developing Drugs.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Developing Drugs
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Mohamed Fahad AlAjmi”
  • BylineArticles whose byline prints “Badraddin Mohammed Al-Hadiya”
  • BylineArticles whose byline prints “Kamal Eldin Hussein El Tahir”